BNGO Bionano Genomics: Rasio rega marang prakiraan pendapatan

Logo grafis Bionano Genomics Inc. (BNGO)

Bionano Genomics, Inc. (BNGO) generates revenue through the long-term sale of chips for Saphyr systems, creating a high-margin payment stream. The forward P/S trend confirms this potential, while 0.40 captures the current value of the indicator. However, success depends on the pace of laboratory adoption and the volume of grants. Outsourcing hardware assembly while maintaining full control over proprietary software mitigates these risks.

BNGO Bionano Genomics Inc.: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Bionano Genomics, Inc.

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Analisis kabeh metrik perusahaan:BNGO (Bionano Genomics Inc.)
Sampel barang bionanogenomics.com

For Bionano Genomics, Inc. (BNGO), whose genome mapping systems are not yet generating stable profits, the estimated P/S ratio measures market capitalization against projected revenue, revealing the gap between investor expectations and actual business scaling. Analyzing the trend of the expected P/S allows for a determination of whether the share price is supported by confidence in sales growth or if the company is becoming vulnerable due to capital depletion and technological stagnation.

Analisis perusahaan pesaing

Multiplikator Forward P/S TEM (Tempus Labs)|Qiagen N.V. - Rasio rega marang prakiraan pendapatan|IONS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep repligen.com|RNA: Multiplikator Forward P/S|CRISPR Therapeutics Inc (CRSP) - Multiplikator Forward P/S|WGS (GeneDx Holdings) - Multiplikator Forward P/S|RARE: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan BEAM (Beam Therapeutics Corp)|SRPT: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S TWST (Twist Bioscience Inc)|Rasio kapitalisasi marang dodolan sing dikarepake 10x Genomics Corp (TXG)|intelliatx.com - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Stoke STOK|biolifesolutions.com (BLFS) - Rasio rega marang prakiraan pendapatan|WVE - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan MAZE|Multiplikator forward rega marang pendapatan Sionna Therapeutics, Inc. (SION)|Multiplikator forward rega marang pendapatan PRME (Prime Medicine Bio)|Rasio kapitalisasi marang dodolan sing dikarepake Taysha|uniQure Pharma - Multiplikator forward rega marang pendapatan|MeiraGTx Holdings plc - Rasio rega marang prakiraan pendapatan|regenxbio.com - Multiplikator Forward P/S|Solid Bio (SLDB) - Multiplikator forward rega marang pendapatan|OCGN: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pacific Biosciences of California|BNTC (Benitec Biopharma Inc.) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan DSGN (Design Therapeutics)|Multiplikator Forward P/S RCKT|Rasio rega marang prakiraan pendapatan FDMT (4D Molecular Therapeutics Inc)|Multiplikator Forward P/S LXEO (Lexeo Therapeutics Inc.)|Rega forward marang dodolan KRRO|EDIT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Silence Therapeutics SLN|ProQR Therapeutics NV (PRQR) - Rasio rega marang prakiraan pendapatan|Codexis Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Sangamo BioSciences|Kapitalisasi marang prakiraan pendapatan NAUT (Nautilus Biotechnology)|Rasio rega marang prakiraan pendapatan metagenomi.co (MGX)|DTIL: Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Generation Bio Co. GBIO|BOLD: Kapitalisasi marang prakiraan pendapatan|XCUR: Multiplikator forward rega marang pendapatan|Imunon (IMNN) - Multiplikator forward rega marang pendapatan|PHIO (RXi Pharmaceuticals) - Multiplikator forward rega marang pendapatan|MBIO (Mustang Bio Inc) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan TransCode Therapeutics, Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Applied DNA Sciences, Inc. APDN|Multiplikator Forward P/S BLUE|ImmunoPrecise Antibodies Ltd - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Omega Therapeutics OMGA|OMIC: Kapitalisasi marang prakiraan pendapatan|RGLS: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio, Inc. (TBIO) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TCON (TRACON)|Rasio rega marang prakiraan pendapatan Unity Biotechnology, Inc.